Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial von Bissonnette, Robert, Pavel, Ana B., Diaz, Aisleen, Werth, John L., Zang, Chuanbo, Vranic, Ivana, Purohit, Vivek S., Zielinski, Michael A., Vlahos, Bonnie, Estrada, Yeriel D., Saint-Cyr Proulx, Etienne, Ports, William C., Guttman-Yassky, Emma

Volltext

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)... von Schlessinger, Joel, Shepard, Julie S., Gower, Richard, Su, John C., Lynde, Charles, Cha, Amy, Ports, William C., Purohit, Vivek, Takiya, Liza, Werth, John L., Zang, Chuanbo, Vlahos, Bonnie

Volltext

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale von Farrar, John T, Young, James P, LaMoreaux, Linda, Werth, John L, Poole, R.Michael

Volltext

Nonrestorative Sleep as a Distinct Component of Insomnia von ROTH, Thomas, ZAMMIT, Gary, LANKFORD, Alan, MAYLEBEN, David, STERN, Theresa, PITMAN, Verne, CLARK, David, WERTH, John L

Volltext

PF-06649751 efficacy and safety in early Parkinson’s disease: a randomized, placebo-controlled trial von Riesenberg, Robert, Werth, John, Zhang, Yao, Duvvuri, Sridhar, Gray, David

Volltext

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis von Fowler, Joseph, Sugarman, Jeffrey, Sher, Lawrence, Zang, Chuanbo, Werth, John L., Myers, Daniela E., Graham, Daniela, Marfo, Alexander Agyei, Takiya, Liza

Volltext

Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis von Geng, Bob, Hebert, Adelaide A., Takiya, Liza, Miller, Lauren, Werth, John L., Zang, Chuanbo, Sanders, Paul, Lebwohl, Mark G.

Volltext

Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities von Spergel, Jonathan M., Blaiss, Michael S., Lio, Peter, Kessel, Aharon, Cantrell, Wendy C., Takiya, Liza, Werth, John L., O'Connell, Michael A., Zang, Chuanbo, Cork, Michael J.

Volltext

Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis von Geng, Bob, Hebert, Adelaide A., Takiya, Liza, Miller, Lauren, Werth, John L., Zang, Chuanbo, Sanders, Paul, Lebwohl, Mark G.

Volltext

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: A placebo-controlled, multicenter study von PANDE, Atul C, FELTNER, Douglas E, DUBOFF, Eugene, PHELPS, Mary, JANNEY, Carol A, WERTH, John L, JEFFERSON, James W, DAVIDSON, Jonathan R, POLLACK, Mark, STEIN, Murray B, LYDIARD, R. Bruce, FUTTERER, Rise, ROBINSON, Paula, SLOMKOWSKI, Mary

Volltext

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy von Pande, Atul C, Crockatt, Jerri G, Janney, Carol A, Werth, John L, Tsaroucha, Georgia

Volltext

A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam von Snyder, Peter J., Werth, John, Giordani, Bruno, Caveney, Angela F., Feltner, Douglas, Maruff, Paul

Volltext

How modeling and simulation have enhanced decision making in new drug development von MILLER, Raymond, EWY, Wayne, LI, Cheryl S. W, WERTH, John L, FELTNER, Douglas E, LALONDE, Richard L, CORRIGAN, Brian W, OUELLET, Daniele, HERMANN, David, KOWALSKI, Kenneth G, LOCKWOOD, Peter, KOUP, Jeffrey R, DONEVAN, Sean, EL-KATTAN, Ayman

Volltext

Effect of renal impairment on the pharmacokinetics of PD 0200390, a novel ligand for the voltage‐gated calcium channel alpha‐2‐delta subunit von Corrigan, Brian, Feltner, Douglas E., Ouellet, Daniele, Werth, John L., Moton, Allen E., Gibson, Gordon

Volltext

288 Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial von Gower, Richard, Xu, JinHua, Alam, Maryam S, Su, John C, Myers, Daniela E, Sanders, Paul, Vlahos, Bonnie, Zang, Chuanbo, Lan, Jar, Werth, John 

Volltext

26993 Efficacy and safety of crisaborole by body region in infants with mild-to-moderate atopic dermatitis von Schlessinger, Joel, Shepard, Julie S., Forsha, Douglass W., Zaenglein, Andrea L., Werth, John L., Zang, Chuanbo, Cha, Amy, Takiya, Liza

Volltext

Efficacy Trends With Continuous Long-Term Use of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis (AD) von Lebwohl, Mark, Hebert, Adelaide, Takiya, Liza, Miller, Lauren, Werth, John, Zang, Chuanbo, Sanders, Paul, Geng, Bob

Volltext

Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With Comorbid Allergic Rhinitis or Asthma von Spergel, Jonathan, Blaiss, Michael, Lio, Peter, Kessel, Aharon, Takiya, Liza, Werth, John, O'Connell, Michael, Zang, Chuanbo, Cork, Michael

Volltext

Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin von Kim, Madeline, Del Duca, Ester, Cheng, Julia, Carroll, Britta, Facheris, Paola, Estrada, Yeriel, Cha, Amy, Werth, John, Bissonnette, Robert, Nocka, Karl, Zang, Chuanbo, Pavel, Ana B., Guttman-Yassky, Emma

Volltext

14248 Efficacy and safety trends with continuous long-term use of 2% crisaborole ointment in patients with mild to moderate atopic dermatitis von Lebwohl, Mark G., Hebert, Adelaide A., Takiya, Liza, Miller, Lauren E., Werth, John L., Zang, Chuanbo, Sanders, Paul, Geng, Bob

Volltext